Quantitative Assessment of Skeletal Tumor Burden in Bone Scintigraphy as a prognostic biomarker in Radium-223-dichloride Therapy

被引：0
|
作者：
Soeiro, P. [1 ]
Silva, R. [1 ,2 ]
Gil, P. [1 ]
Pena, H. [3 ]
Cantinho, G. [3 ]
Costa, G. [1 ,4 ]
Lima, A. [1 ]
Ferreira, I. [1 ]
Alburqueque, A. [1 ]
Gouveia, P. [5 ]
Pedroso Lima, J. [1 ,2 ,4 ]
机构：
[1] Univ Hosp Ctr Coimbra, Coimbra, Portugal
[2] ICNAS Inst Nucl Sci Appl Hlth, Coimbra, Portugal
[3] Univ Lisbon, Fac Med, Inst Nucl Med, Lisbon, Portugal
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
[5] Hosp Ctr Porto, Porto, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0669
引用
收藏
页码：S566 / S567
页数：2
相关论文
共 50 条
  • [31] 223Ra-dichloride SPECT and planar quantitative images for targeted alpha-emitting therapy of bone metastases
    Benabdallah, N.
    Bernardini, M.
    de Labriolle-Vaylet, C.
    Franck, D.
    Desbree, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S396 - S396
  • [32] Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases
    McKay, Rana R.
    Bosse, Dominick
    Gray, Kathryn P.
    Michaelson, M. Dror
    Krajewski, Katherine
    Jacene, Heather A.
    Walsh, Meghara
    Bellmunt, Joaquim
    Pomerantz, Mark
    Harshman, Lauren C.
    Choueiri, Toni K.
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4081 - 4088
  • [33] Prognostic Role Of 18F-Choline PET/CT Vs Bone Scintigraphy In Prostate Cancer Patients Treated With 223Ra-Dichloride.
    Garcia Zoghby, L.
    Cruz Montijano, M.
    Garcia Vicente, A.
    Amo Salas, M.
    Padilla Bermejo, A.
    Lucas Lucas, C.
    Sicilia Pozo, N.
    Contreras Ameduri, M.
    Pena Pardo, F.
    Noriega Alvarez, E.
    Talavera Rubio, M.
    Poblete Garcia, V.
    Soriano Castrejon, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S653 - S653
  • [34] FDG PET/CT as a tool to provide the prognostic stratification and response assessment of metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride (Ra-223)
    Bauckneht, M.
    Capitanio, S.
    Fornarini, G.
    Ceriani, V.
    Ippoliti, M.
    Ciarmiello, A.
    Giovacchini, G.
    Bongioanni, F.
    Piccardo, E.
    Agnese, G.
    Di Ciolo, L.
    Sambuceti, G.
    Morbelli, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S527 - S528
  • [35] Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy
    Etchebehere, Elba C.
    Araujo, John C.
    Milton, Denai R.
    Erwin, William D.
    Wendt, Richard E., III
    Swanston, Nancy M.
    Fox, Patricia
    Macapinlac, Homer A.
    Rohren, Eric M.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (04) : 268 - 273
  • [36] Bone scintigraphy to evaluate response to therapy with Radium-223 for castration-resistant prostate cancer patients with bone metastases: a single-center experience
    Martinez Albero, E.
    Gomez Grande, A.
    Saviatto Nardi, A.
    Galiana Moron, A.
    Vega Perez, D.
    Godigna Guilloteau, V.
    Pilkington Woll, J.
    Ruiz Solis, S.
    Sarandeses Fernandez, P.
    Tabuenca Mateo, M.
    Estenoz Alfaro, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S696
  • [37] Radium-223 dichloride monotherapy and combination therapy with zoledronic acid or doxorubicin improve survival in a mouse model of breast cancer bone metastasis.
    Suominen, Mari I.
    Rissanen, Jukka P.
    Kakonen, Rami
    Fagerlund, Katja M.
    Alhoniemi, Esa
    Mumberg, Dominik
    Ziegelbauer, Karl
    Halleen, Jussi M.
    Kakonen, Sanna-Maria
    Scholz, Arne
    CANCER RESEARCH, 2013, 73 (08)
  • [38] 223Ra-dichloride SPECT and planar quantitative images for targeted alpha-emitting therapy of bone metastases.
    Benabdallah, Nadia
    Bernardini, Michela
    de Labriolle-Vaylet, Claire
    Franck, Didier
    Desbree, Aurelie
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [39] Radium-223 dichloride exhibits dual mode-of-action inhibiting both tumor and tumor-induced bone growth in two osteoblastic prostate cancer models
    Suominen, Mari I.
    Fagerlund, Katja M.
    Rissanen, Jukka P.
    Konkol, Yvonne
    Morko, Jukka
    Peng, Zhiqi
    Alhoniemi, Esa
    Mumberg, Dominik
    Ziegelbauer, Karl
    Kakonen, Sanna-Maria
    Halleen, Jussi M.
    Vessella, Robert L.
    Scholz, Arne
    CANCER RESEARCH, 2015, 75
  • [40] Prognostic value of PSMA PET-derived skeleton tumor burden parameters for overall survival in patients undergoing radium-223 treatment
    Gafita, A.
    Wang, H.
    Kroenke, M.
    Weber, W.
    Tauber, R.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S47 - S48
12345